Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysis.

Aims: Treatment of multiple sclerosis (MS) relapses consists of short-term administration of high-dose glucocorticoids (GCs). However, over 40% of patients show an insufficient response to GC treatment. We aimed to develop a predictive model for such GC resistance.